Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy

Fig. 1

Clinical pathway algorithm to evaluate eligibility for voretigene neparvovec gene therapy. *Refer to Table 1 for further information. FAF fundus autofluorescence, EORP early-onset retinitis pigmentosa, ERG electroretinography, FA Fundus albipunctatus; FST full-field light sensitivity threshold; IRD inherited retinal disease, LCA Leber congenital amaurosis, NGS next-generation sequencing, OCT optical coherence tomography, RP retinitis pigmentosa, RPE retinal pigment epithelium, VA visual acuity, GVF Goldmann visual field, VN voretigene neparvovec, VR vitreoretinal

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172